DEXAMETHASONE ACETATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dexamethasone Acetate, and what generic alternatives are available?
Dexamethasone Acetate is a drug marketed by Watson Labs and Watson Labs Teva and is included in two NDAs.
The generic ingredient in DEXAMETHASONE ACETATE is dexamethasone acetate. There is one drug master file entry for this compound. Additional details are available on the dexamethasone acetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DEXAMETHASONE ACETATE?
- What are the global sales for DEXAMETHASONE ACETATE?
- What is Average Wholesale Price for DEXAMETHASONE ACETATE?
Summary for DEXAMETHASONE ACETATE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 87 |
| Patent Applications: | 324 |
| DailyMed Link: | DEXAMETHASONE ACETATE at DailyMed |
Recent Clinical Trials for DEXAMETHASONE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Shanxi Bethune Hospital | PHASE4 |
| Tianjin Cancer Hospital Airport Hospital | PHASE4 |
| Shaanxi Provincial Cancer Hospital | PHASE4 |
Anatomical Therapeutic Chemical (ATC) Classes for DEXAMETHASONE ACETATE
US Patents and Regulatory Information for DEXAMETHASONE ACETATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | DEXAMETHASONE ACETATE | dexamethasone acetate | INJECTABLE;INJECTION | 084315-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs Teva | DEXAMETHASONE ACETATE | dexamethasone acetate | INJECTABLE;INJECTION | 087711-001 | May 24, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
